Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tolbutamide Sodium Salt
2. 473-41-6
3. Sodium Tolbutamide
4. Orinase Diagnostic
5. Tolbutamide Sodium, Sterile
6. Tolbutamide Sodium, Sterile [usp]
7. E830vc49w5
8. Benzenesulfonamide, N-((butylamino)carbonyl)-4-methyl-, Monosodium Salt
9. Sodium;butylcarbamoyl-(4-methylphenyl)sulfonylazanide
10. Sodium Butamide
11. Sodium Orinase
12. Unii-e830vc49w5
13. 1-butyl-3-(p-tolylsulfonyl)urea Monosodium Salt
14. P-toluenosulfonylbutylomocznik, Sol Sodowa [polish]
15. P-toluenosulfonylbutylomocznik, Sol Sodowa
16. Orinase Diagnostic (tn)
17. Urea, 1-butyl-3-(p-tolylsulfonyl)-, Sodium Salt
18. Chembl1200874
19. Dtxsid50197090
20. Tolbutamide Sodium [vandf]
21. Tolbutamide Sodium [who-dd]
22. Tolbutamide Sodium Salt [mi]
23. Tolbutamide Sodium [orange Book]
24. D06177
25. Q27276989
26. 1-butyl-3-(p-tolylsulfonyl)urea, Monosodium Salt
27. Sodium;n'-butyl-n-(4-methylphenyl)sulfonylcarbamimidate
| Molecular Weight | 292.33 g/mol |
|---|---|
| Molecular Formula | C12H17N2NaO3S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 292.08575786 g/mol |
| Monoisotopic Mass | 292.08575786 g/mol |
| Topological Polar Surface Area | 72.6 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 360 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sodium Orinase manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Orinase, including repackagers and relabelers. The FDA regulates Sodium Orinase manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Orinase API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Orinase supplier is an individual or a company that provides Sodium Orinase active pharmaceutical ingredient (API) or Sodium Orinase finished formulations upon request. The Sodium Orinase suppliers may include Sodium Orinase API manufacturers, exporters, distributors and traders.
Sodium Orinase Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Orinase GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Orinase GMP manufacturer or Sodium Orinase GMP API supplier for your needs.
A Sodium Orinase CoA (Certificate of Analysis) is a formal document that attests to Sodium Orinase's compliance with Sodium Orinase specifications and serves as a tool for batch-level quality control.
Sodium Orinase CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Orinase CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Orinase may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Orinase EP), Sodium Orinase JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Orinase USP).
LOOKING FOR A SUPPLIER?
